(Q43782027)

26 November 2017

title

Prognostic value of platelet-derived growth factor in patients with severe sepsis (English)

1 reference

26 November 2017

0 references

10

Martin Borggrefe

1 reference

26 November 2017

1

Martina Brueckmann

1 reference

26 November 2017

2

Ursula Hoffmann

1 reference

26 November 2017

4

Siegfried Lang

1 reference

26 November 2017

Cathleen Engelhardt

3

1 reference

26 November 2017

Kenji Fukudome

5

1 reference

26 November 2017

Karl K Haase

6

1 reference

26 November 2017

Volker Liebe

7

1 reference

26 November 2017

Jens J Kaden

8

1 reference

26 November 2017

Christian Putensen

9

1 reference

26 November 2017

Guenter Huhle

11

1 reference

26 November 2017

publication date

1 February 2007

1 reference

26 November 2017

published in

Growth Factors Journal

1 reference

26 November 2017

volume

25

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

15-24

1 reference

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Structure and functions of the endothelial cell protein C receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Activation of endothelial cell protease activated receptor 1 by the protein C pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Activated protein C inhibits the expression of platelet-derived growth factor in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190701272784

10.1080/08977190701272784

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference